Molecular structure of 3-Hydroxyphenazepam, CAS Number: 70030-11-4
3-Hydroxyphenazepam (CAS 70030-11-4)
Alternate Names:
3-hydroxy BD 98; 3-hydroxy Fenazepam
CAS Number:
70030-11-4
Molecular Weight:
365.61
Molecular Formula:
C15H10BrClN2O2
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
* Refer to Certificate of Analysis for lot specific data.
QUICK LINKS
Ordering Information
Description
Technical Information
Safety Information
SDS & Certificate of Analysis
3-Hydroxyphenazepam (3-OHP) acts as a GABA agonist by binding to the GABA receptor and stimulating the release of GABA. This mechanism enhances GABAergic activity, leading to decreased neuronal excitability and increased activity of inhibitory neurons. 3-Hydroxyphenazepam (3-OHP) is classified as a benzodiazepine compound.
3-Hydroxyphenazepam (CAS 70030-11-4) References
- Biokinetics of transdermal 3-hydroxyphenazepam. | Golovenko, NY., et al. 2002. Bull Exp Biol Med. 134: 254-6. PMID: 12511995
- [Peculiarities of hypnotic effect and pharmacokinetics of hemisuccinate 3-hydroxyphenazepam (levana)]. | Voronina, TA., et al. 2014. Eksp Klin Farmakol. 77: 3-6. PMID: 24649593
- Analysis of phenazepam and 3-hydroxyphenazepam in post-mortem fluids and tissues. | Crichton, ML., et al. 2015. Drug Test Anal. 7: 926-36. PMID: 25847502
- Patterns of drug abuse among drug users with regular and irregular attendance for treatment as detected by comprehensive UHPLC-HR-TOF-MS. | Sundström, M., et al. 2016. Drug Test Anal. 8: 39-45. PMID: 26017246
- Detectability of designer benzodiazepines in CEDIA, EMIT II Plus, HEIA, and KIMS II immunochemical screening assays. | Pettersson Bergstrand, M., et al. 2017. Drug Test Anal. 9: 640-645. PMID: 27366870
- Characterization and in vitro phase I microsomal metabolism of designer benzodiazepines - an update comprising adinazolam, cloniprazepam, fonazepam, 3-hydroxyphenazepam, metizolam and nitrazolam. | Moosmann, B., et al. 2016. J Mass Spectrom. 51: 1080-1089. PMID: 27535017
- Comparison of Post-targeted and Pre-targeted Urine Drug Screening by UHPLC-HR-QTOFMS. | Sundström, M., et al. 2017. J Anal Toxicol. 41: 623-630. PMID: 28873975
- Experimental versus theoretical log D7.4 , pKa and plasma protein binding values for benzodiazepines appearing as new psychoactive substances. | Manchester, KR., et al. 2018. Drug Test Anal.. PMID: 29582576
- Designer Benzodiazepines: Another Class of New Psychoactive Substances. | Moosmann, B. and Auwärter, V. 2018. Handb Exp Pharmacol. 252: 383-410. PMID: 30367253
- Characterization and in vitro phase I microsomal metabolism of designer benzodiazepines: An update comprising flunitrazolam, norflurazepam, and 4'-chlorodiazepam (Ro5-4864). | Moosmann, B., et al. 2019. Drug Test Anal. 11: 541-549. PMID: 30578721
- Validation of an LC-MS/MS Method for the Quantification of 13 Designer Benzodiazepines in Blood. | Mei, V., et al. 2019. J Anal Toxicol. 43: 688-695. PMID: 31436813
- GABAA receptor agonist cinazepam and its active metabolite 3-hydroxyphenazepam act differently at the presynaptic site. | Borisova, T., et al. 2021. Eur Neuropsychopharmacol. 45: 39-51. PMID: 33820715
- Designer Benzodiazepines: A Review of Toxicology and Public Health Risks. | Brunetti, P., et al. 2021. Pharmaceuticals (Basel). 14: PMID: 34208284
- [Characteristics of fenazepam excretion in rats and mice]. | Zherdev, VP. and Ekonomov, AL. 1983. Farmakol Toksikol. 46: 32-7. PMID: 6134636
- [Simulation of kinetics of phenazepam and its metabolite 3-hydroxyphenazepam in cat blood]. | Zherdev, VP., et al. 1982. Biull Eksp Biol Med. 94: 54-6. PMID: 7171799
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
3-Hydroxyphenazepam, 5 mg | sc-491228 | 5 mg | $300.00 |